News
The first patient has been enrolled in the ARID II trial evaluating Voro Urologic Scaffold to improve continence after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback